Quick Answer (for busy buyers)
Applicable requirements and regulatory responsibilities depend on product classification and target market. Confirm the responsible parties and any filing or update obligations for your specific project.
- For a US-market diaper rash cream, we start with a water-in-oil (w/o) emulsion base.
- This structure provides the lasting occlusive barrier.
- We then incorporate 15-25% zinc oxide (often micronized for smoothness) as the key protective and soothing agent.
- Spreadability is engineered by balancing the oil phase viscosity with emulsifiers and adding light silicones or esters for glide, without compromising the barrier integrity.
- Lab batches are rigorously tested for texture, pH, and stability under accelerated conditions.
- The final formula must be non-irritating and pass preservative efficacy testing (PET) per USP 51.
- We can support full safety documentation, including a Cosmetic Product Safety Report compliant with MoCRA.
- MOQ typically starts at 5k-10k units, driven by custom tube/bottle tooling and batch size for stability testing.
- Lead time from approved formula to pilot run is 8-10 weeks, allowing for critical pediatric-use claim testing and label review with your legal team.
Buyer outcome
Use the answer to clarify requirements, compare options, and prepare project questions.
Before requesting a quote
Confirm the target market, product type, packaging requirements, and unresolved details.
⚠️
This page is a practical buyer guide. For regulatory topics, verify current requirements with the relevant authorities and qualified advisers for your product and target market.
